BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30958383)

  • 1. Diabetes Promotes Development of Alzheimer's Disease Through Suppression of Autophagy.
    Miao Y; Guo D; Li W; Zhong Y
    J Alzheimers Dis; 2019; 69(1):289-296. PubMed ID: 30958383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calpastatin Mediates Development of Alzheimer's Disease in Diabetes.
    Zhu L; Gong L; Yang T; Xiao X
    J Alzheimers Dis; 2019; 68(3):1051-1059. PubMed ID: 30909245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.
    Plaschke K; Kopitz J; Siegelin M; Schliebs R; Salkovic-Petrisic M; Riederer P; Hoyer S
    J Alzheimers Dis; 2010; 19(2):691-704. PubMed ID: 20110613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminished parkin solubility and co-localization with intraneuronal amyloid-β are associated with autophagic defects in Alzheimer's disease.
    Lonskaya I; Shekoyan AR; Hebron ML; Desforges N; Algarzae NK; Moussa CE
    J Alzheimers Dis; 2013; 33(1):231-47. PubMed ID: 22954671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-β and tau pathology of Alzheimer's disease induced by diabetes in a rabbit animal model.
    Bitel CL; Kasinathan C; Kaswala RH; Klein WL; Frederikse PH
    J Alzheimers Dis; 2012; 32(2):291-305. PubMed ID: 22785400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes-Induced H3K9 Hyperacetylation Promotes Development of Alzheimer's Disease Through CDK5.
    Cai HB; Fan ZZ; Tian T; Li ZC; Zhao CC; Guo WT; Ge ZM
    J Alzheimers Dis; 2020; 77(1):75-84. PubMed ID: 32310180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy-lysosome dysfunction is involved in Aβ deposition in STZ-induced diabetic rats.
    Ma LY; Lv YL; Huo K; Liu J; Shang SH; Fei YL; Li YB; Zhao BY; Wei M; Deng YN; Qu QM
    Behav Brain Res; 2017 Mar; 320():484-493. PubMed ID: 27773683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Mechanism of Autophagy: Its Role in the Therapy of Alzheimer's Disease.
    Zhao Y; Zhang Y; Zhang J; Zhang X; Yang G
    Curr Neuropharmacol; 2020; 18(8):720-739. PubMed ID: 31934838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy and exosomes; inter-connected maestros in Alzheimer's disease.
    Atya HB; Sharaf NM; Abdelghany RM; El-Helaly SN; Taha H
    Inflammopharmacology; 2024 Jun; 32(3):2061-2073. PubMed ID: 38564092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic Control of CDK5 Promoter Regulates Diabetes-Associated Development of Alzheimer's Disease.
    Cai HB; Fan ZZ; Tian T; Zhao CC; Ge ZM
    J Alzheimers Dis; 2019; 69(3):743-750. PubMed ID: 31156174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Implications of Autophagy in Alzheimer's Disease.
    Hamano T; Hayashi K; Shirafuji N; Nakamoto Y
    Curr Alzheimer Res; 2018; 15(14):1283-1296. PubMed ID: 30289076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimentally induced diabetes worsens neuropathology, but not learning and memory, in middle aged 3xTg mice.
    Hayashi-Park E; Ozment BN; Griffith CM; Zhang H; Patrylo PR; Rose GM
    Behav Brain Res; 2017 Mar; 322(Pt B):280-287. PubMed ID: 27173425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer's disease.
    Knezovic A; Osmanovic-Barilar J; Curlin M; Hof PR; Simic G; Riederer P; Salkovic-Petrisic M
    J Neural Transm (Vienna); 2015 Apr; 122(4):577-92. PubMed ID: 25808906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
    Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
    eNeuro; 2017; 4(2):. PubMed ID: 28374012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain aging and AD-like pathology in streptozotocin-induced diabetic rats.
    Wang JQ; Yin J; Song YF; Zhang L; Ren YX; Wang DG; Gao LP; Jing YH
    J Diabetes Res; 2014; 2014():796840. PubMed ID: 25197672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy-dependent mechanism of genistein-mediated elimination of behavioral and biochemical defects in the rat model of sporadic Alzheimer's disease.
    Pierzynowska K; Podlacha M; Gaffke L; Majkutewicz I; Mantej J; Węgrzyn A; Osiadły M; Myślińska D; Węgrzyn G
    Neuropharmacology; 2019 Apr; 148():332-346. PubMed ID: 30710571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycemia induces tau hyperphosphorylation.
    Lee CW; Shih YH; Wu SY; Yang T; Lin C; Kuo YM
    Curr Alzheimer Res; 2013 Mar; 10(3):298-308. PubMed ID: 23036024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.